"GLP-1 friendly" labels arent regulated by the Food and Drug Administration, says Caroline Susie, RDN, LD , a spokesperson for the Academy of Nutrition and Dietetics
Ideal ist die letzte Dosis am spten Nachmittag
Mechanistically, an in vitro study found that exendin-4 inhibited the secretion of IL-1 and TNF- from mouse colonic smooth muscle cells (CSMCs) via the pathway mediated by cAMP and NF-B, thereby exerting anti-inflammatory effects [218]
Tips for managing side effects when switching If you switch GLP-1 medications, you may experience gastrointestinal side effects such as nausea, diarrhea, stomach pain, appetite reduction, constipation, bloating, and excessive burping
This appetite suppressant is approved by the FDA for short-term use for up to 12 weeks, though some healthcare providers prescribe it off-label for longer-term use